Early research (Phase 1)Study completedNCT00004880What this trial is testingVaccine Therapy in Treating Patients With Advanced Kidney CancerWho this might be right forKidney Cancer Jonsson Comprehensive Cancer Center 14
Not applicableActive Not RecruitingNCT03185039What this trial is testingPredictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic AgentsWho this might be right forKidney Cancer Institut Paoli-Calmettes 50
Testing effectiveness (Phase 2)Study completedNCT00066612What this trial is testingS0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With ChemotherapyWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer SWOG Cancer Research Network 45
Testing effectiveness (Phase 2)Study completedNCT01034631What this trial is testingBNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Hoosier Cancer Research Network 154
Testing effectiveness (Phase 2)Study completedNCT00316901What this trial is testingPositron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical TrialWho this might be right forKidney CancerMelanoma (Skin) National Institutes of Health Clinical Center (CC) 70
Large-scale testing (Phase 3)Study completedNCT00087022What this trial is testingMonoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney CancerWho this might be right forKidney Cancer Heidelberg Pharma AG 864
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Testing effectiveness (Phase 2)Ended earlyNCT00303862What this trial is testingAZD2171 in Treating Patients With Refractory Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Ended earlyNCT00090870What this trial is testingPEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Medical University of South Carolina 10
Testing effectiveness (Phase 2)Ended earlyNCT00617929What this trial is testingAntithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantWho this might be right forCancer Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Study completedNCT02643303What this trial is testingTremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible CancersWho this might be right forHead and Neck Squamous Cell CarcinomaBreast CancerSarcoma+8 more Ludwig Institute for Cancer Research 58
Testing effectiveness (Phase 2)Study completedNCT01024205What this trial is testingSunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney CancerWho this might be right forKidney Cancer Barts and the London School of Medicine and Dentistry 43
Testing effectiveness (Phase 2)Temporarily pausedNCT00033956What this trial is testingEvaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2Who this might be right forIL-2 Induced Hypotension MetaPhore Pharmaceuticals 48
Not applicableStudy completedNCT04501913What this trial is testingRemote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported OutcomesWho this might be right forClinical Stage 0 Esophageal Adenocarcinoma AJCC v8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage 0 Gastric Cancer AJCC v8+169 more City of Hope Medical Center 22
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35
Testing effectiveness (Phase 2)WithdrawnNCT00489710What this trial is testingTalabostat in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer University of Nebraska
Testing effectiveness (Phase 2)UnknownNCT00003181What this trial is testingInterleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Hope Cancer Institute, Inc. 35
Testing effectiveness (Phase 2)Ended earlyNCT03393936What this trial is testingSafety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Shanghai PerHum Therapeutics Co., Ltd. 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT05411081What this trial is testingTesting Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 TrialWho this might be right forMetastatic Papillary Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8 National Cancer Institute (NCI) 200
Early research (Phase 1)Study completedNCT01826877What this trial is testingAutologous Dendritic Cells in Treating Patients With Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer Jonsson Comprehensive Cancer Center 12